A novel FOXP3 gene variant causing neonatal diabetes and fatal enteropathy
Article information
To the editor,
A 42-day-old male infant born to a nonconsanguineous couple presented with osmotic symptoms for 10 days and rapid breathing for one day. He was diagnosed with neonatal diabetes mellitus (NDM) and severe (pH- 7.0, HCO3- 4 mEq/L) diabetic ketoacidosis (DKA). He was initiated on a basal-bolus insulin regimen after DKA resolution. Antenatal, birth, and perinatal histories were unremarkable. Family history revealed type 2 diabetes in the grandparents. His anthropometric parameters were: weight 3.8 kg (z-score, -1.78), length 51 cm (z-score, -2.46), and occipito-frontal circumference 37 cm (z-score, -0.59). No dysmorphic features, skeletal anomalies, hepatomegaly, or neurological deficits were noted on physical examination. His glycated hemoglobin and stimulated C-peptide concentrations were 9.1% and 0.232 ng/mL, respectively. He failed a glibenclamide trial (up to 2 mg/kg/day). A next-generation sequencing panel for NDM was performed.
At 3 months of age, the baby developed persistent watery diarrhea (8–10 episodes/day). Upon readmission, he showed severe dehydration, metabolic acidosis, and absence of ketosis. At this time, the total daily insulin dose was 0.9 units/kg/day. There was severe growth failure, with a weight of 4.0 kg (z-score, -4.74) and a length of 58 cm (z-score, -2.38). The child received intravenous fluids, zinc, and antibiotics. Sepsis markers, including C-reactive protein, were negative, suggesting a noninfective etiology. Despite supportive measures, metabolic acidosis (pH 7.2, HCO3- 12 mEq/L) persisted, and the child died on day 3 of hospitalization following aspiration. Postmortem genetic analysis revealed a novel hemizygous missense variant in exon 8 of the FOXP3 gene: c.756G> T(p.Lys252Asn). This variant was not previously reported in the 1000 Genomes and GnomAD databases, or in our own NDM cohort [1]. The in silico predictions of the variant are possibly damaging on PolyPhen-2 and damaging on SIFT and Mutation Taster2. The lysine at codon 252 is highly conserved across species, indicating functional importance. Parental samples were not available for genetic investigation; we have taken this into consideration when classifying the variant. According to ACMG (American College of Medical Genetics and Genomics) rules, the variant is classified as likely pathogenic with the following criteria: PM2 (pathogenic moderate 2) moderate, PM6 (pathogenic moderate 6) moderate, PP2 (pathogenic supporting 2) suggestive, and PP3 (pathogenic supporting 3) suggestive. Although the lack of functional studies is a limitation, the genotype-phenotype correlation strongly supports the variant’s role in causing this disease.
IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome results from variants in the forkhead box P3 (FOXP3) gene encoding FOXP3 protein, which controls genes for regulatory T cells. Only about 300 affected individuals have been identified worldwide [2]. The typical presentation begins during early infancy with enteropathy (malabsorptive or watery diarrhea), followed by endocrinopathy (usually type 1 diabetes), and eczematous dermatitis. A few reported patients manifested NDM first, as in our case [3,4]. Other clinical features include nephropathy, cytopenia, hepatitis, lymphadenopathy, splenomegaly, alopecia, arthritis, and interstitial lung disease [2,3], which were absent in the index case. Mortality remains high; most children die within the first 1–2 years of life. Aggressive immunosuppression or hematopoietic stem cell transplantation offers hope for survival [2].
Our findings underscore the importance of considering IPEX syndrome in the differential diagnosis of neonatal diabetes, particularly when accompanied by intractable, noninfective diarrhea.
Notes
Conflicts of interest
No potential conflict of interest relevant to this article was reported.
